page_head_bg

Products

liriopesides B

Short Description:

Common Name: Ophiopogon saponin B
English Name: liriopesides B
CAS No.: 87425-34-1
Molecular Weight: 722.902
Density: 1.3 ± 0.1 g / cm3
Boiling Point: 823.3 ± 65.0 ° C at 760 mmHg
Molecular Formula: C39H62O12
Melting Point: n / A
MSDS: N / A
Flash Point: 451.7 ± 34.3 ° C


Product Detail

Product Tags

Application Of Spicatoside B

Spicatoside B (nolinospiroside f) is a steroidal saponin isolated from Ophiopogon japonicas. Liriopesides B has antioxidant and anti-aging effects.

Name Of Spicatoside B

Chinese Name: Spicatoside B

English Name:

β-D-Galactopyranoside, (1β,3β,25S)-3-[(6-deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy

 Bioactivity of Spicatoside B

Description: liliopeside B (nolinospiroside f) is a steroidal saponin isolated from Ophiopogon japonicas. Liriopesides B has antioxidant and anti-aging effects.

Related categories: research field > > other

Signal path > > other > > other

In Vitro Study: aristolochic glycoside B (nolinopiroside f) increases SIRT1 activity [1]

. Physicochemical Properties Of Spicatoside B
Density: 1.3 ± 0.1 g / cm3
Boiling Point: 823.3 ± 65.0 ° C at 760 mmHg
Molecular Formula: c39h62o12
Molecular Weight: 722.902
Flash Point: 451.7 ± 34.3 ° C
Exact Mass: 722.424133
PSA:176.76000
LogP:5.42
Steam Pressure: 0.0 ± 0.6 mmHg at 25 ° C
Refractive Index: 1.604

 English Alias Of Spicatoside B

(1β,3β,25S)-3-[(6-Deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy-β-D-galactopyranoside

β-D-Galactopyranoside, (1β,3β,25S)-3-[(6-deoxy-α-L-mannopyranosyl)oxy]spirost-5-en-1-yl 6-deoxy-

Liriopesides B

Spirostan, β-D-galactopyranoside deriv.

Liriopeside b

Nolinospiroside F

Product Quality Control

1. The company purchased nuclear magnetic resonance (Bruker 400MHz) spectrometer, liquid phase mass spectrometer (LCMS), gas phase mass spectrometer (GCMs), mass spectrometer (water SQD), multiple automatic analytical high performance liquid chromatographs, preparative liquid chromatographs, etc.
2. The company maintains close cooperation and contact with scientific research institutions such as Shanghai Institute for drug control, Nanjing biomedical public service platform and analysis and testing center of Shanghai Pharmaceutical Industry Research Institute.
3. The company is actively carrying out laboratory third-party testing and certification, and will obtain CNAs laboratory accreditation certificate at the end of 2021.


  • Previous:
  • Next:

  • Write your message here and send it to us